Table 3 Thyroid function according to different pathologic classifications.
From: The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study
 | MCD | MPGN | MsPGN | MN | FSGS | IgAN | Secondary | P# |
---|---|---|---|---|---|---|---|---|
N | 110 | 7 | 9 | 98 | 15 | 27 | 51 | — |
Age (Year) | 34.29 ± 16.17 | 38.86 ± 8.88 | 40.89 ± 15.09 | 47.85 ± 13.69* | 41.64 ± 17.48 | 38.04 ± 15.31 | 42.8 ± 14.88 | <0.001 |
Male (%) | 55.5% | 71.4% | 33.3% | 55.2% | 45.5% | 34.6% | 60.8% | 0.250 |
FT3 (pmol/L) | 3.09 ± 1.06 | 3.07 ± 0.91 | 2.95 ± 0.97 | 3.91 ± 1.75* | 3.66 ± 1.63 | 3.36 ± 1.17 | 3.24 ± 1.02 | 0.001 |
TT3 (nmol/L) | 1.16 ± 0.49 | 0.53 ± 0.1 | 1.09 ± 0.39 | 1.49 ± 0.43* | 1.27 ± 0.1 | 1.31 ± 0.17 | 1.45 ± 0.41 | 0.058 |
FT4 (pmol/L) | 12.68 ± 3.22 | 12.92 ± 2.25 | 13.47 ± 4 | 13.68 ± 3.53* | 14.51 ± 4.55 | 14.09 ± 3.67 | 13.59 ± 3.34 | 0.256 |
TT4 (nmol/L) | 59.33 ± 21.24 | 44.61 ± 0.3 | 78.79 ± 22.78* | 73.99 ± 22.61* | 106.5 ± 0.2* | 91.09 ± 14.05* | 79.85 ± 29.38* | 0.014 |
TSH (mU/L) | 5.42 ± 5.29 | 3.31 ± 1.64 | 3.7 ± 2.59 | 4.36 ± 2.81 | 4.33 ± 3.44 | 5.38 ± 3.94 | 6.45 ± 13.63 | 0.571 |
RT3 (nmol/L) | 0.27 ± 0.13 | 0.33 ± 0.1 | 0.43 ± 0.06 | 0.35 ± 0.19 | 0.29 ± 0.15 | 0.3 ± 0.1 | 0.3 ± 0.15 | 0.403 |
Thyroid subgroups | Â | Â | Â | Â | Â | Â | Â | 0.028 |
Normal Thyroid (%) | 14.81% | 28.57% | 0.00% | 23.00% | 18.18% | 23.08% | 16.00% | Â |
Subclinical Hypothyroidism (%) | 12.04% | 14.29% | 11.11% | 28.00% | 27.27% | 23.08% | 16.00% | Â |
Hypothyroidism (%) | 37.04% | 14.29% | 22.22% | 18.00% | 9.09% | 19.23% | 30.00% | Â |
Low T3 (%) | 19.44% | 0.00% | 33.33% | 15.00% | 18.18% | 26.92% | 30.00% | Â |
Low T4 (%) | 0.93% | 0.00% | 0.00% | 4.00% | 0.00% | 0.00% | 0.00% | Â |
Low T3T4 (%) | 15.74% | 42.86% | 33.33% | 12.00% | 27.27% | 7.69% | 8.00% | Â |